摩根基金 - 基因治療主題基金 - JPM基因治療主題(美元) - A股(累計)
106.98美元1.79(1.7%)
2024/07/25更新
績效 / 1月9.88%
3月16.2%
1年5.4%
晨星評等-
- 1.現金0.70%
- 2.股票21.95%
- 3.債券0.00%
- 4.其他77.35%
- 1.美國77.34%
- 2.歐洲不包含歐元區8.18%
- 3.日本5.17%
- 4.歐元區3.93%
- 5.大洋洲2.21%
- 1.Alnylam Pharmaceuticals Inc3.78%
- 2.Sarepta Therapeutics Inc3.68%
- 3.Krystal Biotech Inc3.38%
- 4.Novartis AG Registered Shares3.36%
- 5.Vertex Pharmaceuticals Inc3.26%
- 6.Ionis Pharmaceuticals Inc3.20%
- 7.Vericel Corp2.93%
- 8.Bio-Techne Corp2.92%
- 9.Biomarin Pharmaceutical Inc2.92%
- 10.Biogen Inc2.91%
- 1.現金0.70%
- 2.股票21.95%
- 3.債券0.00%
- 4.其他77.35%
- 1.美國77.34%
- 2.歐洲不包含歐元區8.18%
- 3.日本5.17%
- 4.歐元區3.93%
- 5.大洋洲2.21%
- 1.Alnylam Pharmaceuticals Inc3.78%
- 2.Sarepta Therapeutics Inc3.68%
- 3.Krystal Biotech Inc3.38%
- 4.Novartis AG Registered Shares3.36%
- 5.Vertex Pharmaceuticals Inc3.26%
- 6.Ionis Pharmaceuticals Inc3.20%
- 7.Vericel Corp2.93%
- 8.Bio-Techne Corp2.92%
- 9.Biomarin Pharmaceutical Inc2.92%
- 10.Biogen Inc2.91%